Overview
Updated 14 Jul 2026
Vincent T. Ho, MD, is Director of Clinical Operations, Stem Cell Transplantation at Dana-Farber Cancer Institute. The public record shows 667 publications with 27,406 citations (h-index 86), centered on Multiple Myeloma, MDS / MPN, Lymphoma. It also documents an investigator role on 12 registered clinical trials, industry payments reported by 8 companies, 2 NIH-funded awards (2009–2025).
- Most recent indexed publication: 2026 · Journal of clinical oncology
- Top research focus: Multiple Myeloma
- 12 registered trials on ClinicalTrials.gov
- Open Payments reporting from 8 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 4 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 12 registered studies on ClinicalTrials.gov. The most recent:
- Blast Overpressure Longitudinal Study
Sponsor: Uniformed Services University of the Health Sciences
InvestigatorNot, yet, recruitingNCT07606651 - Prokinetics and Body Surface Gastric Mapping in Dyspeptic Patients: Baseline and Treatment Effects
Sponsor: University of Auckland, New Zealand
InvestigatorRecruitingNCT06854120 - Body Surface Gastric Mapping Vs Gastric Emptying Scintigraphy on Clinical Management in Gastroparesis
Sponsor: University of Western Sydney
InvestigatorRecruitingNCT06411574
Industry payments
Updated 14 Jul 2026
8 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Alexion Pharmaceuticals, Inc.Program year20253 payments
- Novo Nordisk IncProgram year20253 payments
- JAZZ PHARMACEUTICALS INC.Program year20251 payment
NIH funding
Updated 14 Jul 2026
2 NIH research awards on record, funded 2009–2025 per NIH RePORTER. The latest:
- Systematic identification of minor histocompatibility antigens to address GVHD
Dana-Farber Cancer Inst
FY2025$768,238R01HL157174 - Systematic identification of minor histocompatibility antigens to address GVHD
Dana-Farber Cancer Inst
FY2024$723,738R01HL157174 - Systematic identification of minor histocompatibility antigens to address GVHD
Dana-Farber Cancer Inst
FY2023$738,508R01HL157174
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- User-Centered Development of the MyCare(2) Comprehensive Digital Support Platform for Caregivers of Individuals With Cancer.
JCO clinical cancer informatics
2026
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
450 Brookline Avenue, Boston, MA 02215
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗
- Residency
Internal Medicine, Brigham and Women's Hospital
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗ - Fellowship
Medical Oncology, Dana-Farber/Partners CancerCare
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗
Editorial & leadership rolesjournal and society appointments
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗
- Institute Physician
Dana-Farber Cancer Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗ - Member
Leukemia Program and Lymphoma/Myeloma Program, Dana-Farber/Harvard Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dfhcc.harvard.edu ↗
Awards & honorshonors on the public record
- Top Doctor (Boston Magazine / Castle Connolly)
2026, also recognized in prior years including 2019 and 2020
2020verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗
Media & interviewspress, podcasts and appearances
- "Pulling Back the Curtain: Vincent Ho, MD"
profile feature, ASH Clinical News (American Society of Hematology), May 2
2017provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ashpublications.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/vincent-ho-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by otherswhere others cite or feature them
- Other
ashpublications.org/ashclinicalnews/news/2710/Pulling-Back-the-Curtain-Vincent-Ho-MD
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ashpublications.org ↗ - Other
blog.dana-farber.org/insight/2015/05/doctors-journey-out-of-saigon-inspires-clinical-career
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →blog.dana-farber.org ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Nikhil Munshi, MD
Dana-Farber Cancer Institute
- 1,801
- publications
- 152
- h-index
- 8
- trials
Patrick Wen, MD
Dana-Farber Cancer Institute
- 1,915
- publications
- 146
- h-index
- 27
- trials
Geoffrey Shapiro, MD
Dana-Farber Cancer Institute
- 2,055
- publications
- 116
- h-index
- 24
- trials
Irene Ghobrial, MD
Dana-Farber Cancer Institute
- 1,124
- publications
- 101
- h-index
- 16
- trials